Some New Myocardial Infarction Codes Challenge Interpretation

By
Original story posted on: July 17, 2017
The addendum for new codes coming out was recently released with many notable additions and deletions. The next several articles in this series will address some of these conditions in order to help us get ready for the October 1 implementation date.

One of the things I love most about getting the codes well before the implementation date is the time it allows us to update our systems, especially our templates to facilitate great documentation habits early on.

This article is going to focus on the new codes for myocardial infarction (MI)—specifically, the newer codes for the type 2 MIs as well as the rest of the additions in the new category.

Clinical documentation improvement (CDI) efforts will be well-spent trying to capture the information regarding an acute MI or the type 2 MI. When working with physicians, documentation of the five types of MIs (listed below) will help speed code assignments and improve quality reporting.

The new category in ICD-10-CM went through several rounds of proposals and revisions and is finally debuting.  We have several new codes to choose from as well as some revisions.

Before we go over the coding changes though, it’s important to understand the documentation for the different types. This will help coders to choose the correct codes and CDI specialists to better assist the physician in documenting these concepts.

The problem with type 2 MIs is that the definition is slightly hard to interpret. It is defined, according to the American College of Cardiology, as myocardial infarction secondary to ischemia due to either increased oxygen demand or decreased supply. Examples given are coronary artery spasm, coronary embolism, anemia, arrhythmias, hypertension or hypotension.

Determining the type, which is based on proposed pathological, clinical and prognostic differentiators, helps to determine the strategy needed to treat.

  • Type 1
    • Spontaneous MI
      • Ischemia-caused coronary event, such as plaque rupture, erosion, fissuring or dissection

  • Type 2
    • Secondary to an ischemia
      • Ischemia caused by increased oxygen demand or decreased supply, such as coronary endothelial dysfunction, coronary artery spasm, coronary artery spasm or embolism, tachy- or brady arrhythmias, anemia, respiratory failure, hypotension and hypertension

  • Type 3
    • Cardiac death due to MI
      • Sudden unexpected cardiac death with symptoms of suggestive myocardial ischemia that is accompanied by presumably new ST elevation, new left bundle branch block (LBBB), or evidence of fresh thrombus in a coronary artery by angiography or at autopsy. Death occurs before blood samples can be obtained or before the time that cardiac biomarkers in the blood.

  • Type 4a
    • Percutaneous coronary intervention (PCI) related MI

  • Type 4b
    • MI related to stent thrombosis

  • Type 5
    • Coronary arterial bypass graft (CABG) related MI

Type 4 and Type 5 MIs related to PCI are further classified as periprocedural MI and stent thrombosis. PCI and CABG related MIs are defined by specific thresholds in conjunction with evidence of ischemia, demonstrated loss of myocardium or overt clinical conditions.

Category I21 was changed from ST elevation (STEMI) and non-ST elevation myocardial infarction (NSTEMI) to acute myocardial infarction. The Excludes2 note changes from subsequent myocardial infarction (I22.-) to subsequent type 1 myocardial infarction (I22.-)

Instructional notes at the fourth character designate anatomical location as before but add the type 1 ST elevation myocardial infarction designation.

I21.9 is not for acute myocardial infarction, unspecified (NOS).

The new subcategories for “other type of myocardial infarction” include:

I21.A Other type of myocardial infarction

          I21.A1 Myocardial infarction type 2

                   Myocardial infarction due to demand ischemia

                   Myocardial infarction secondary to ischemic imbalance

                   Code also the underlying cause, if known and applicable, such as:

                             Anemia (D50.0–D64.9)

                             Chronic obstructive pulmonary disease (J44)

                             Heart failure (I50-)

                             Paroxysmal tachycardia (I47.0–I47.9)

                             Renal failure (N17.0–N19)

                             Shock (R57.0–R57.9)

I21.A9 Other myocardial infarction type

          Myocardial infarction associated with revascularization

          Myocardial infarction type 3

          Myocardial infarction type 4a

          Myocardial infarction type 4b

          Myocardial infarction type 4c

          Myocardial infarction type 5

          Code first, if applicable, postprocedural myocardial infarction following cardiac surgery

(I97, I90), or postprocedural myocardial infarction during cardiac surgery (I97.790)

Code also complication, if known and applicable, such as:

                   (acute) stent occlusion (T82.897-)

                   (acute) stent stenosis (T82.857-)

                   (acute) stent thrombosis (T82.867-)

                   cardiac arrest due to underlying cardiac condition (I46.2)

                   complication of percutaneous coronary intervention (PCI) (I97.89)

                   occlusion of coronary artery bypass graft (T82.218-)

The next article in this series will go over changes for the eye and adnexa. As always, continuing to learn the clinical conditions will assist in code selection and help with CDI improvement efforts.
Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.
Rhonda Buckholtz, CPC, CPMA, CPC-I, CRC, CDEO, CHPSE, COPC, CPEDC, CGSC

Rhonda Buckholtz is the vice president of practice optimization for Eye Care Leaders. She has more than 25 years of experience in healthcare, working in the management, reimbursement, billing, and coding sectors, in addition to being an instructor. She is a past co-chair for the WEDI ICD-10 Implementation Workgroup, Advanced Payment Models Workgroup and has provided testimony ongoing for ICD-10 and standardization of data for NCVHS. Rhonda spends her time on practice optimization for Eye Care Leaders by providing transformational services and revenue integrity for Ophthalmology practices. She was instrumental in developing the Certified Ophthalmology Professional Coder (COPC) exam and curriculum for the AAPC. Rhonda is a member of the ICD10monitor editorial board and makes frequent appearances on Talk Ten Tuesdays.

Related Stories

  • Things Your Mother Never Told You About HCC: Version 23
    The 2019 CMS risk adjustment model is version 23. The Centers for Medicare & Medicaid Services (CMS) released, in April, the latest update to the CMS-hierarchical condition category (HCC) Risk Adjustment Model (V23).  It applies to payment year 2019.  As…
  • Tracing the Evolution of Clinical Documentation Integrity
    CDI is the critical link to quality outcomes.   Any healthcare system’s overall performance relies heavily on a strong clinical documentation integrity (CDI) program, and therefore on the professionals at the heart of this discipline. From patient outcomes and mortality…
  • Random Thoughts about ICD-11
    New classification system noted for granularity. Several of my colleagues recently attended an ICD-11 presentation by Kathy Giannangelo[i] at the American Health Information Management Association (AHIMA) Convention & Exhibit. Kathy has been in the trenches with ICD-11’s development for some…